FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/104110 [Registered on: 17/02/2026] Trial Registered Prospectively
Last Modified On: 11/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Siddha 
Study Design  Other 
Public Title of Study   A Study on Peichori Kudineer(Internal) and Sainthavaathi Lebanam(External) for the treatment of SEETHAPITHAM (URTICARIA) in the Paediatric age group. 
Scientific Title of Study   A Preclinical and double-arm clinical Study to evaluate the Therapeutic efficacy of PEICHORI KUDINEER (Internal) and SAINTHAVAATHI LEBANAM (External) in the Management of SEETHA PITHAM(URTICARIA) in the Paediatric age group. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Y S SHILPAASHRI 
Designation  PG SCHOLAR 
Affiliation  Government Siddha Medical College and Hospital,Palayamkottai 
Address  PG Second Year,Department of Kuzhanthai Maruthuvam,Government siddha Medical College and Hospital,Palayamkottai

Tirunelveli
TAMIL NADU
627002
India 
Phone  9486993446  
Fax    
Email  shriyuvaraj23@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr A ANBUMALAR MD S  
Designation  Lecturer 
Affiliation  Government Siddha Medical College and Hospital,Palayamkottai 
Address  Department of Kuzhanthai Maruthuvam,Government siddha Medical College and Hospital,Palayamkottai

Tirunelveli
TAMIL NADU
627002
India 
Phone  9788232433  
Fax    
Email  anbumalara@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr A ANBUMALAR MD S  
Designation  Lecturer 
Affiliation  Government Siddha Medical College and Hospital,Palayamkottai 
Address  Department of Kuzhanthai Maruthuvam,Government Siddha Medical College and Hospital,Palayamkottai.

Tirunelveli
TAMIL NADU
627002
India 
Phone  9788232433  
Fax    
Email  anbumalara@gmail.com  
 
Source of Monetary or Material Support  
Government Siddha Medical College and Hospital Palayamkottai,Tirunelveli 627002 
 
Primary Sponsor  
Name  Dr Y S SHILPAASHRI 
Address  PG Second Year,Department of Kuzhanthai Maruthuvam,Government siddha Medical College and Hospital,Palayamkottai 627002 
Type of Sponsor  Other [self ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Y S SHILPAASHRI  Government Siddha Medical College and Hospital,Palayamkottai  Department of Kuzhanthai Maruthuvam,Government siddha Medical College and Hospital,Palayamkottai-627002
Tirunelveli
TAMIL NADU 
9486993446

shriyuvaraj23@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE 2024 2027 GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL PALAYAMKOTTAI TIRUNELVELI  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L500||Allergic urticaria, (2) ICD-10 Condition: L508||Other urticaria, (3) ICD-10 Condition: L509||Urticaria, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  PEICHORI KUDINEER (Internal)  Should Be Administered Orally Twice a day After Food Dosage (According to age group and body weight)3-12 years- 15-30ml. Duration 7 days.  
Comparator Agent  SAINTHAVAATHI LEBANAM (External)  Topical application - Should be applied externally Duration 7 days. 
 
Inclusion Criteria  
Age From  3.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  Urticaria symptoms like wheals,redness,pruritus,
Allergic reactions which includes Foods,vegetable spices,and fruits
Medications
plants
Food preservatives
Industrial materials
physical stimuli
Insect bite/stings
 
 
ExclusionCriteria 
Details  Children below 2 years and above 12 years
Auto immune cause
Mastocytosis
Stills disease
Atopic dermatitis
Infection induced urticaria
Erythema multiforme 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
The study is expected to prove the safety and efficacy of Peichori Kudineer and Sainthavaathi Lebanam in children with Seethapitham, showing relief in itching, redness, wheals, reduced recurrence, and evidence-based Siddha validation.  The Study Outcomes Including Symptomatic Relief (Reduction in itching,wheals,erythema)Reduction in recurrence and Improvement in quality of life,Will be asessed at predefined time intervals-At Baseline(Day0),During Treatment(Day3) and at the end of Treatment (1 Week)-to evaluate the safety and Therapeutic efficacy of PeichoriKudineer(Internal)and Sainthavaathi Lebanam(External)in the management of Seethapitham (Urticaria) in the Paediatric age group. 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   02/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
BACKGROUND:

This study is planned as a preclinical and double-arm clinical study to evaluate the therapeutic efficacy and safety of Peichori Kudineer (internal) and Sainthavaathi Lebanam (external) in the management of Seetha Pitham (urticaria) in children. The preclinical phase will assess the safety profile of the study drugs, while the clinical phase will include paediatric patients diagnosed with Seetha Pitham. Efficacy will be evaluated based on improvement in urticarial symptoms such as wheals, pruritus, duration, and recurrence, along with safety assessment through clinical monitoring. The study aims to generate scientific evidence for the use of Siddha internal and external medicines in paediatric urticaria.
 
Close